Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Inetetamab + Pyrotinib for HER2 Mutant NSCLC Patients Oct 12, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) BI 1810631 Shows Promise In Patients With Advanced Solid Tumors With HER2 Aberrations Oct 12, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) SG + Pembro Show Early Efficacy And Manageable Safety In 1L mNSCLC Oct 11, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Chemo With SAbR Shows Viability In Newly Diagnosed And Recurrent LA-NSCLC Patients Oct 11, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) 1L Nivolumab + Ipilimumab Show Durable Efficacy Vs. Chemo In Metastatic NSCLC Patients Oct 09, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Datopotamab Deruxtecan + Durvalumab Shows Promise in Advanced Lung Cancer Oct 05, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),SCLC (Small Cell Lung Cancer) Dos Vs. Pem + CT In Previously Untreated Metastatic Non-Squamous NSCLC Oct 05, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) HER3-DXd Shows Efficacy In EGFR-Mutated NSCLC Sep 28, 2023